Technology | Contrast Media | August 05, 2019

Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension

Barium sulfate approval completes NDA Program of the Varibar line of imaging agents for use in modified barium swallow studies

Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension

August 5, 2019 — Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium sulfate) for oral suspension, which is indicated for modified barium swallow (MBS) studies. The contrast agent is used to detect and assess the type and severity of swallowing disorders also known as dysphagia.

In the U.S., approximately 13 million (1 in 25) Americans suffer from dysphagia.1  Dysphagia varies in severity and can be caused by a number of conditions and diseases, such as stroke, traumatic brain injury, dementia, Parkinson's disease, multiple sclerosis, and treatment of head and neck cancer or trauma.1 The most common complications are aspiration pneumonia, malnutrition and dehydration.2  Aspiration pneumonia is a subset of pneumonia caused by inhalation of substances such as liquid and/or food into the lungs when the swallowing mechanism does not function properly. It requires hospitalization and is associated with 10 percent in-hospital mortality and high hospitalization cost, estimated at approximately $30,000 per case.3

An MBS study is performed by a team comprised of a speech language pathologist (SLP) and a radiologist to identify issues with a patient's swallowing mechanism.  During an MBS, the patient swallows products with different thicknesses containing a barium X-ray contrast agent, while the radiologist takes fluoroscopic X-ray images.

Varibar Thin Liquid (barium sulfate) oral suspension requires reconstitution prior to use.

For more information: www.imaging.bracco.com

References

1. Bhattacharyya N. The prevalence of dysphagia among adults in the United States. Otolaryngology–Head and Neck Surgery 2014; 151: 765–769

2. Schindler A, Ginocchio D, Ruoppolo G. What we don't know about dysphagia complications? Rev Laryngol Otol Rhinol (Bord) 2008;129:75-88

3. Wu C-P., Chen Y-W., Wang M-J., et al. National Trends in Admission for Aspirational  Pneumonia in the United States, 2002-2012; Annals ATS 2017, 14: 874-879

Related Content

 Paxera Ultima 360
News | Enterprise Imaging | November 12, 2019
November 12, 2019 — Medical Imaging developer PaxeraHealth will showcase the
 Mammography doctor
News | Breast Imaging | November 12, 2019
November 12, 2019 — Geisinger has partnered with...
 Lunit RSNA
News | Artificial Intelligence | November 12, 2019
November 12, 2019 — Lunit, a leading medical AI software company devoted to provi
 Laurel Bridge Machine Learning workflow
News | Artificial Intelligence | November 08, 2019
November 8, 2019 — Laurel Bridge Software announces the new Laurel Bridge
 RadiForce MX216
News | Flat Panel Displays | November 08, 2019
November 8, 2019 — EIZO Inc. announced the United States release of the Radi
Nov. 8 is the anniversary of the discovery of the X-ray by German physicist Wilhelm Roentgen

Wilhelm Roentgen

News | X-Ray | November 08, 2019
November 8, 2019 — Nov.
The Carestream DRX-Revolution Mobile X-ray System provides fast, convenient digital radiography imaging for patients at the bedside, in the operating room, the intensive care unit or the emergency room
News | Digital Radiography (DR) | November 07, 2019
In response to customer feedback, Carestream has further developed the...